Holly Schachner
Direttore Tecnico/Scientifico/R&S presso DoubleRainbow Biosciences, Inc.
Posizioni attive di Holly Schachner
Società | Posizione | Inizio | Fine |
---|---|---|---|
DoubleRainbow Biosciences, Inc.
DoubleRainbow Biosciences, Inc. BiotechnologyHealth Technology DoubleRainbow Biosciences, Inc. engages in the development of transformative technologies. It explores essential natural ingredients that enhance daily experience and health through food, beverages, cosmetics, supplements, and other consumer products. The company was founded by Jing Ke Weng and Tian Xu and is headquartered in Cambridge, MA. | Direttore Tecnico/Scientifico/R&S | 01/08/2021 | - |
Storia della carriera di Holly Schachner
Precedenti posizioni note di Holly Schachner
Società | Posizione | Inizio | Fine |
---|---|---|---|
APPLIED MOLECULAR TRANSPORT INC. | Direttore/Membro del Consiglio | 23/08/2021 | 27/12/2023 |
Independent Dir/Board Member | 23/08/2021 | 27/12/2023 | |
MYOKARDIA, INC. | Corporate Officer/Principal | 01/09/2020 | 01/04/2021 |
ALLERGAN PLC | Corporate Officer/Principal | 01/03/2019 | 01/07/2020 |
Sanofi SA | Corporate Officer/Principal | 01/01/2014 | 01/01/2019 |
Formazione di Holly Schachner
University of Michigan | Undergraduate Degree |
Stony Brook School | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Francia | 2 |
Posizioni
Corporate Officer/Principal | 3 |
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Settori
Health Technology | 6 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
APPLIED MOLECULAR TRANSPORT INC. | Health Technology |
Aziende private | 4 |
---|---|
DoubleRainbow Biosciences, Inc.
DoubleRainbow Biosciences, Inc. BiotechnologyHealth Technology DoubleRainbow Biosciences, Inc. engages in the development of transformative technologies. It explores essential natural ingredients that enhance daily experience and health through food, beverages, cosmetics, supplements, and other consumer products. The company was founded by Jing Ke Weng and Tian Xu and is headquartered in Cambridge, MA. | Health Technology |
MyoKardia, Inc.
MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Sanofi SA | Health Technology |
- Borsa valori
- Insiders
- Holly Schachner
- Esperienza